35 U.S.C. 371 — National stage: Commencement
Ninth Edition, Revision 01.2024
- (a) Receipt from the International Bureau of copies of international applications with any amendments to the claims, international search reports, and international preliminary examination reports including any annexes thereto may be required in the case of international applications designating or electing the United States.
- (b) Subject to subsection (f) of this section, the national stage shall commence with the expiration of the applicable time limit under article 22 (1) or (2), or under article 39 (1)(a) of the treaty.
- (c) The applicant shall file in the Patent and Trademark
Office—
- (1) the national fee provided in section 41(a) ;
- (2) a copy of the international application, unless not required under subsection (a) of this section or already communicated by the International Bureau, and a translation into the English language of the international application, if it was filed in another language;
- (3) amendments, if any, to the claims in the international application, made under article 19 of the treaty, unless such amendments have been communicated to the Patent and Trademark Office by the International Bureau, and a translation into the English language if such amendments were made in another language;
- (4) an oath or declaration of the inventor (or other person authorized under chapter 11 ) complying with the requirements of section 115 and with regulations prescribed for oaths or declarations of applicants;
- (5) a translation into the English language of any annexes to the international preliminary examination report, if such annexes were made in another language.
- (d) The requirement with respect to the national fee referred to in subsection (c)(1), the translation referred to in subsection (c)(2), and the oath or declaration referred to in subsection (c)(4) of this section shall be complied with by the date of the commencement of the national stage or by such later time as may be fixed by the Director. The copy of the international application referred to in subsection (c)(2) shall be submitted by the date of the commencement of the national stage. Failure to comply with these requirements shall be regarded as abandonment of the application by the parties thereof. The payment of a surcharge may be required as a condition of accepting the national fee referred to in subsection (c)(1) or the oath or declaration referred to in subsection (c)(4) of this section if these requirements are not met by the date of the commencement of the national stage. The requirements of subsection (c)(3) of this section shall be complied with by the date of the commencement of the national stage, and failure to do so shall be regarded as a cancellation of the amendments to the claims in the international application made under article 19 of the treaty. The requirement of subsection (c)(5) shall be complied with at such time as may be fixed by the Director and failure to do so shall be regarded as cancellation of the amendments made under article 34 (2)(b) of the treaty.
- (e) After an international application has entered the national stage, no patent may be granted or refused thereon before the expiration of the applicable time limit under article 28 or article 41 of the treaty, except with the express consent of the applicant. The applicant may present amendments to the specification, claims, and drawings of the application after the national stage has commenced.
- (f) At the express request of the applicant, the national stage of processing may be commenced at any time at which the application is in order for such purpose and the applicable requirements of subsection (c) of this section have been complied with.
(Added Nov. 14, 1975, Public Law 94-131, sec. 1, 89 Stat. 688; amended Nov. 8, 1984, Public Law 98-622, sec. 402(a)-(d), 403(a), 98 Stat. 3391, 3392; subsections (a), (b), (c), (d), and (e) amended Nov. 6, 1986, Public Law, 99-616, sec. 7, 100 Stat. 3486; subsection (c)(1) amended Dec. 10, 1991, Public Law 102-204, sec. 5(g)(2), 105 Stat. 1641; amended Nov. 29, 1999, Public Law 106-113, sec. 1000(a)(9), 113 Stat. 1501A-582 (S. 1948 sec. 4732(a)(10)(A)); subsection (d) amended Nov. 2, 2002, Public Law 107-273, sec. 13206, 116 Stat. 1905; amended Sept. 16, 2011, Public Law 112-29, secs. 20(i) and (j) (effective Sept. 16, 2012), 125 Stat. 284; subsection (d) amended Dec. 18, 2012, Public Law 112-211, sec. 202(b)(9), 126 Stat. 1536.
Cited authority
- PCT Article 22 Copy, Translation, and Fee, to Designated Offices
- PCT Article 39 Copy, Translation, and Fee, to Elected Offices
- 35 U.S.C. 41 Patent fees; patent and trademark search systems
- PCT Article 19 Amendment of the Claims Before the International Bureau
- 35 U.S.C. 111 Application
- 35 U.S.C. 115 Inventor’s oath or declaration
- PCT Article 34 Procedure Before the International Preliminary Examining Authority
- PCT Article 28 Amendment of the Claims, the Description, and the Drawings, Before Designated Offices
- PCT Article 41 Amendment of the Claims, the Description, and the Drawings, before Elected Offices
Cited by
- 1002.02(p) Petitions and Matters Decided by the Director of International Patent Legal Administration
- 1120 Eighteen-Month Publication of Patent Applications
- 1121 Content of a Patent Application Publication
- 1134.01 Third Party Submissions Under 37 CFR 1.290
- 120 Secrecy Orders
- 1450 Restriction and Election of Species Made in Reissue Application
- 1481.03 Correction of 35 U.S.C. 119 and 35 U.S.C. 120 Benefits
- 1490 Disclaimers
- 1504.02 Novelty
- 1504.03 Nonobviousness
- 1803 Reservations Under the PCT Taken by, and Notifications of Incompatibility Made by, the United States of America
- 1805 Where To File an International Application
- 1828 Priority Claim and Document
- 1828.02 Continuation or Continuation-in-Part Indication in the Request
- 1832 License Request for Foreign Filing Under the PCT
- 1850 Unity of Invention Before the International Searching Authority
- 1879.03 Translations
- 1893 National Stage (U.S. National Application Filed Under 35 U.S.C. 371)
- 1893.01 Commencement and Entry
- 1893.01(a) Entry via the U.S. Designated or Elected Office
- 1893.01(a)(1) Submissions Required by 30 Months from the Priority Date
- 1893.01(a)(2) Article 19 Amendment (Filed With the International Bureau)
- 1893.01(b) Applicant for a U.S. National Stage Application
- 1893.01(c) Fees
- 1893.01(d) Translation
- 1893.01(e) Inventor’s Oath or Declaration
- 1893.03(a) How To Identify That an Application Is a U.S. National Stage Application
- 1893.03(b) The Filing Date of a U.S. National Stage Application
- 1893.03(c) The Priority Date, Priority Claim, and Priority Papers for a U.S. National Stage Application
- 1893.03(d) Unity of Invention
- 1893.03(e) Documents Received from the International Bureau and Placed in a U.S. National Stage Application File
- 1893.03(g) Information Disclosure Statement in a National Stage Application
- 1895 A Continuation, Divisional, or Continuation- in- Part Application of a PCT Application Designating the United States
- 1895.01 Handling of and Considerations in the Handling of Continuations, Divisions, and Continuations-In-Part of PCT Applications
- 1896 The Differences Between a National Application Filed Under 35 U.S.C. 111(a) and a National Stage Application Submitted Under 35 U.S.C. 371
- 1901.04 When Can the Protest Be Submitted
- 201.06(c) 37 CFR 1.53(b) and 37 CFR 1.63(d) Divisional-Continuation Procedure
- 210 Priority to, or the Benefit of, the Filing Date of a Prior-Filed Application
- 211 Claiming the Benefit of an Earlier Filing Date Under 35 U.S.C. 120 and 119(e)
- 211.01(c) Claiming the Benefit of an International Application Designating the United States
- 211.02 Reference to Prior Application(s)
- 211.03 Time Period for Making a Claim for Benefit Under 37 CFR 1.78
- 211.04 Delayed Benefit Claims
- 213 Right of Priority of Foreign Application
- 213.02 Formal Requirements Relating to Foreign Priority Application
- 213.03 Time for Filing U.S. Nonprovisional Application
- 213.06 Claiming Priority and Filing a Certified Copy in a National Stage Application (35 U.S.C. 371)
- 2136 Pre-AIA 35 U.S.C. 102(e)
- 2136.03 Critical Reference Date
- 2139 Rejections Under Pre-AIA 35 U.S.C. 102
- 2139.01 Effective Filing Date of a Claimed Invention Under Pre-AIA 35 U.S.C. 102
- 2139.03 Form Paragraphs for Use in Rejections Under Pre-AIA 35 U.S.C. 102
- 214.01 Time for Filing Priority Claim
- 214.03 Office Acknowledgement of Priority Claims
- 2148 Form Paragraphs for Use in Rejections Under Pre-AIA 35 U.S.C. 103
- 215 Certified Copy of Foreign Application
- 215.02 Time For Filing Certified Copy – Application Filed On or After March 16, 2013
- 215.02(a) Timeliness Requirement – Met By Priority Document Exchange
- 215.02(b) Timeliness Requirement – Met By Interim Copy of Foreign Application
- 2150 Examination Guidelines for 35 U.S.C. 102 and 103 as Amended by the First Inventor To File Provisions of the Leahy-Smith America Invents Act
- 2152.01 Effective Filing Date of the Claimed Invention
- 2157 Improper Naming of Inventors
- 2159.01 Applications Filed Before March 16, 2013
- 216 Entitlement to Priority
- 216.01 Perfecting Claim for Priority Under 35 U.S.C. 119(a)-(d) or (f) After Issuance of a Patent
- 2414.01 Issuance of a Notice Relating to the Requirements For Patent Applications Containing Nucleotide and/or Amino Acid Sequence Disclosures
- 2415 Applicability date of “Sequence Listing XML” Requirements to Applications Based on Filing Date of Application and Procedures for Failure to Submit Correct Format of Sequence Listing
- 2415.01 Determining if a “Sequence Listing XML” Must be Submitted
- 2417 Helpful Hints for Sequence Rules Compliance under WIPO Standard ST.26
- 2421.03 Notification of a Failure to Comply
- 2422 Nucleotide and/or Amino Acid Sequence Disclosures in Patent Applications Subject to WIPO ST.25
- 2422.03 Sequence Listing Submission
- 2422.03(a) “Sequence Listing” Submitted as ASCII Plain Text Files
- 2422.04 The Requirement for a Computer Readable Copy of the “Sequence Listing”
- 2422.06 Requirement for Statement Regarding Information Contained in the “Sequence Listing” and Separate Computer Readable Form
- 2422.07 Requirements for Compliance and Consequences of Non-Compliance
- 2429 Helpful Hints for Sequence Rules Compliance under WIPO ST.25
- 2434 Examination of Patent Applications Claiming Large Numbers of Nucleotide Sequences
- 2504 Patents Subject to Maintenance Fees
- 2506 Times for Submitting Maintenance Fee Payments
- 2701 Patent Term
- 2730 Applications Filed on or After May 29, 2000; Grounds for Adjustment
- 2731 Period of Adjustment
- 2732 Reduction of Period of Adjustment of Patent Term
- 2920.01 Inventorship
- 2920.05(d) Foreign Priority
- 2920.05(e) Benefit Claims Under 35 U.S.C. 386(c)
- 308 Issue to Applicant
- 409.05 Application For Patent by an Assignee, Obligated Assignee, or a Person Who Otherwise Shows Sufficient Proprietary Interest – Application Filed On or After September 16, 2012
- 502.05 Correspondence Transmitted by EFS-Web
- 509 Payment of Fees
- 509.01 Deposit Accounts
- 601.05 Bibliographic Information - Application Data Sheet (ADS)
- 601.05(a) Application Data Sheet (ADS) -- Application Filed On or After September 16, 2012
- 601.05(b) Application Data Sheet (ADS) in Application Filed Before September 16, 2012
- 602.01 Naming the Inventor; Inventor's Oath or Declaration
- 602.01(a) Inventor’s Oath or Declaration in Application Filed On or After September 16, 2012
- 602.08(b) Inventor Signature and Name
- 602.08(c) Identification of Application
- 605.01 Applicant for Application filed on or after September 16, 2012
- 605.02 Applicant for Application Filed Before September 16, 2012
- 607 Filing Fee
- 608.01 Specification
- 608.01(b) Abstract of the Disclosure
- 608.02(c) Location of Drawings
- 608.02(d) Complete Illustration in Drawings
- 608.05 “Sequence Listing,” “Large Tables,” or “Computer Program Listing Appendix” Submitted in ASCII Plain Text or a “Sequence Listing XML” Submitted as XML File Text
- 609.03 Information Disclosure Statements in National Stage Applications
- 609.04(b) Timing Requirements for an Information Disclosure Statement
- 704.10 Requirements for Information
- 704.11 What Information May Be Required
- 706.07(g) Transitional After-Final Practice
- 706.07(h) Request for Continued Examination (RCE) Practice
- 708.01 List of Special Cases
- 708.02 Petition To Make Special
- 708.02(a) Accelerated Examination
- 708.02(b) Prioritized Examination
- 714.01(e) Amendments Before First Office Action
- 801 Introduction
- 802 Basis for Restriction Practice in Statute and Rules
- 803.04 Nucleotide Sequences
- 804 Definition of Double Patenting
- 804.01 Prohibition of Nonstatutory Double Patenting Rejections Under 35 U.S.C. 121
- 804.03 Commonly Owned Inventions of Different Inventive Entities; Non-Commonly Owned Inventions Subject to a Joint Research Agreement
- 823 Unity of Invention Under the Patent Cooperation Treaty
- 904 How to Search
- 35 U.S.C. 41 Patent fees; patent and trademark search systems
- 35 U.S.C. 115 Inventor’s oath or declaration
- 35 U.S.C. 154 Contents and term of patent; provisional rights
- 35 U.S.C. 154 (pre-AIA) Contents and term of patent; provisional rights
- 35 U.S.C. 366 Withdrawn international application
- 37 CFR 1.21 Miscellaneous fees and charges
- 37 CFR 1.25 Deposit accounts
- 37 CFR 1.41 Inventorship
- 37 CFR 1.41 (pre-AIA) Applicant for patent
- 37 CFR 1.46 Application for patent by an assignee, obligated assignee, or a person who otherwise shows sufficient proprietary interest in the matter
- 37 CFR 1.52 Language, paper, writing, margins, read-only optical disc specifications
- 37 CFR 1.55 Claim for foreign priority
- 37 CFR 1.58 Chemical and mathematical formulas and tables
- 37 CFR 1.76 Application data sheet
- 37 CFR 1.78 Claiming benefit of earlier filing date and cross-references to other applications
- 37 CFR 1.102 Advancement of examination
- 37 CFR 1.105 (pre-AIA) Requirements for information
- 37 CFR 1.114 Request for continued examination
- 37 CFR 1.211 Publication of applications
- 37 CFR 1.215 Patent application publication
- 37 CFR 1.215 (pre-AIA) Patent application publication
- 37 CFR 1.362 Time for payment of maintenance fees
- 37 CFR 1.414 The United States Patent and Trademark Office as a Designated Office or Elected Office
- 37 CFR 1.491 National stage commencement, entry, and fulfillment
- 37 CFR 1.491 (pre-AIA) National stage commencement and entry
- 37 CFR 1.492 National stage fees
- 37 CFR 1.495 Entering the national stage in the United States of America
- 37 CFR 1.495 (pre-AIA) Entering the national stage in the United States of America
- 37 CFR 1.497 Inventor’s oath or declaration under 35 U.S.C. 371(c)(4)
- 37 CFR 1.497 (pre-AIA) Oath or declaration under 35 U.S.C. 371(c)(4)
- 37 CFR 1.702 Grounds for adjustment of patent term due to examination delay under the Patent Term Guarantee Act of 1999 (original applications, other than designs, filed on or after May 29, 2000)
- 37 CFR 1.702 (pre-2013-04-01) Grounds for adjustment of patent term due to examination delay under the Patent Term Guarantee Act of 1999 (original applications, other than designs, filed on or after May 29, 2000)
- 37 CFR 1.703 Period of adjustment of patent term due to examination delay
- 37 CFR 1.703 (2012-09-17 thru 2013-03-31) Period of adjustment of patent term due to examination delay
- 37 CFR 1.703 (pre-2012-09-17) Period of adjustment of patent term due to examination delay
- 37 CFR 1.704 Reduction of period of adjustment of patent term
- 37 CFR 1.704 (2013-12-18 thru 2015-03-09) Reduction of period of adjustment of patent term
- 37 CFR 1.704 (2012-09-17 thru 2013-12-17) Reduction of period of adjustment of patent term
- 37 CFR 1.821 Nucleotide and/or amino acid sequence disclosures in patent applications
- 37 CFR 1.835 Amendment to add or replace a “Sequence Listing XML” in patent applications filed on or after July 1, 2022